Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Neil Bertelsen"'
Autor:
Stuart D Faulkner, Suzanne Sayuri Ii, Chi Pakarinen, Fabian Somers, Maria Jose Vicente Edo, Lucia Prieto Remon, Ana Diaz Ponce, Dianne Gove, Elisa Ferrer, Begonya Nafria, Neil Bertelsen, Mathieu Boudes, Nicholas Brooke, Alexandra Moutet, Nick Fahy
Publikováno v:
Health Expectations, Vol 24, Iss 2, Pp 601-616 (2021)
Abstract Background The holistic evolution of patient engagement in medicines development requires a more detailed understanding of the needs of all involved stakeholders, and one that better accounts for the specific needs of some potentially vulner
Externí odkaz:
https://doaj.org/article/9366a38501dc4d2da686b3eb9815f3ea
Autor:
Anke-Peggy Holtorf, Neil Bertelsen
Publikováno v:
Farmeconomia: Health Economics and Therapeutic Pathways, Vol 17, Iss 1, Pp 3-6 (2016)
Externí odkaz:
https://doaj.org/article/5ecc55a7995e43a4adfde443d440f351
Autor:
Vinciane Pirard, Kirsty Reid, Maria Cavaller-Bellaubi, Juan García-Burgos, Eva Molero, Stuart Faulkner, Neil Bertelsen, María J. Vicente, Nicholas Brooke, Laura McKeaveney, Mathieu Boudes, Jeffrey Southerton, Elisa Ferrer, Bryan Teixeira
Publikováno v:
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universitat Politècnica de Catalunya (UPC)
Therapeutic Innovation & Regulatory Science
Universitat Politècnica de Catalunya (UPC)
Therapeutic Innovation & Regulatory Science
Background There is increased recognition that incorporating patients’ perspectives and insights into the medicines development process results in better health outcomes and benefits for all involved stakeholders. Despite the increased interest and
Autor:
Irina Mountian, Zoltán Kaló, Sheela Upadhyaya, Neil Bertelsen, Grammati Sarri, Andreas Freitag, Diana I. Brixner, Boglarka Szegvari
Publikováno v:
Health Policy. 125:593-601
•The value of patient experience is becoming increasingly recognized by healthcare stakeholders.•Integration of patient experience in health technology assessment is not universally adopted.•This is challenging when assessing complex health tec
Autor:
Karlin Schroeder, Neil Bertelsen, Jessica Scott, Katherine Deane, Laura Dormer, Devika Nair, Jim Elliott, Sarah Krug, Ify Sargeant, Hayley Chapman, Nicholas Brooke
Publikováno v:
Therapeutic innovationregulatory science. 56(5)
Patients’ experiences of their diagnosis, condition, and treatment (including the impact on their lives), and their experiences surrounding expectations of care, are becoming increasingly important in shaping healthcare systems that meet the evolvi
Autor:
Sarah Berglas, Nicola Bedlington, Neil Bertelsen, Karen Facey, Victoria Thomas, Ann N. V. Single
Publikováno v:
The Patient - Patient-Centered Outcomes Research. 11:581-589
Health technology assessments (HTAs) are meant to inform health policy by taking account of all the potential impacts of using a health technology. In the 1990s, HTAs included rigorous research to produce patient-based evidence, and some supported pa
Autor:
Katarina Halling, Anna Georgieva, Neil Bertelsen, John-Kenneth Sake, Danie Du Plessis, Jackie Morgan
Publikováno v:
Therapeutic innovationregulatory science. 51(4)
Various health care bodies (regulatory, health technology assessment, academia, health care providers, scientific journals) request patient input in their decision-making processes. This represents a shift from disease-centered to patient-centered ap
Autor:
Nicholas Brooke, Mathieu Boudes, Ify Sargeant, Marc Boutin, Paul Robinson, Anton Hoos, Neil Bertelsen, Jan Geissler
Publikováno v:
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy
Background Meaningful patient engagement (PE) in medicines development and during the life cycle of a product requires all stakeholders have a clear understanding of respective expectations. Objective A qualitative survey was undertaken to understand
Publikováno v:
Research Involvement and Engagement
Health Technology Assessment (HTA) is an evidence-based decision-making process, focusing on evaluating health technologies for funding within a healthcare system. ‘Health technologies’ include medications, medical devices, diagnostics, medical p
Publikováno v:
Patient Involvement in Health Technology Assessment ISBN: 9789811040672
This chapter reflects on some key themes emerging in this book. The book provides a starting point for HTA bodies and academics to consider, research, develop, pilot and implement patient involvement processes in collaboration with patients and other
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9502160d49e8b55a63ef593a2fe7f9c5
https://doi.org/10.1007/978-981-10-4068-9_37
https://doi.org/10.1007/978-981-10-4068-9_37